Osteopore Ltd. (OSX) Price & Analysis

Q: What was Osteopore Ltd.’s price range in the past 12 months?

Osteopore Ltd. lowest share price was <AU$0.01 and its highest was AU$0.05 in the past 12 months.

Q: What is Osteopore Ltd.’s market cap?

Osteopore Ltd.’s market cap is AU$2.61M.

Q: When is Osteopore Ltd.’s upcoming earnings report date?

Osteopore Ltd.’s upcoming earnings report date is Aug 28, 2025 which is yesterday.

Q: How were Osteopore Ltd.’s earnings last quarter?

Osteopore Ltd. released its earnings results on Feb 28, 2025. The company reported -AU$0.015 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.015.

Q: Is Osteopore Ltd. overvalued?

According to Wall Street analysts Osteopore Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Osteopore Ltd. pay dividends?

Osteopore Ltd. does not currently pay dividends.

Q: What is Osteopore Ltd.’s EPS estimate?

Osteopore Ltd.’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Osteopore Ltd. have?

Osteopore Ltd. has 237,259,980 shares outstanding.

Q: What happened to Osteopore Ltd.’s price movement after its last earnings report?

Osteopore Ltd. reported an EPS of -AU$0.015 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Q: Which hedge fund is a major shareholder of Osteopore Ltd.?

Currently, no hedge funds are holding shares in AU:OSX

Compare

9 Followers

OSX Stock Chart & Stats

Day’s Range― - ―

52-Week Range<AU$0.01 - AU$0.05

Previous CloseN/A

Volume70.28K

Average Volume (3M)5.34M

Market Cap

AU$2.61M

Enterprise ValueAU$4.78M

Total Cash (Recent Filing)AU$638.50K

Total Debt (Recent Filing)AU$1.33M

Price to Earnings (P/E)―

Beta4.07

Next Earnings

Aug 28, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.01

Shares Outstanding237,259,980

10 Day Avg. Volume3,116,464

30 Day Avg. Volume5,342,213

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusHold

Number of Analyst Covering0

Osteopore Ltd. News

Osteopore Partners with Universiti Malaya for Innovative Dental Surgery Study

Osteopore Ltd. ( ($AU:OSX) ) has shared an update. Osteopore Limited has initiated a clinical study in collaboration...

21d ago

OSX

Osteopore Secures Key Tender Wins in Vietnam’s Growing Orthopaedic Market

Osteopore Ltd. ( ($AU:OSX) ) has shared an update. Osteopore Ltd. has successfully won tender bids to supply...

25d ago

OSX

Osteopore Ltd. Announces Quotation of New Securities on ASX

Osteopore Ltd. ( ($AU:OSX) ) has issued an announcement. Osteopore Ltd. has announced the quotation of 30,120,481 ordinary...

29d ago

OSX

Osteopore Achieves Record Revenue and EU MDR Clearance

Osteopore Ltd. ( ($AU:OSX) ) has issued an update. Osteopore Limited has reported a record quarterly revenue of...

29d ago

OSX

Osteopore Reports Triple Growth in Sales Through Zimmer Biomet Partnership

An announcement from Osteopore Ltd. ( ($AU:OSX) ) is now available. Osteopore Limited has reported significant progress following...

1M ago

OSX

Osteopore Ltd. Announces Change in Substantial Shareholding

An announcement from Osteopore Ltd. ( ($AU:OSX) ) is now available. Osteopore Ltd. has announced a change in...

1M ago

OSX

Advance Opportunities Fund Ceases Substantial Holding in Osteopore

An announcement from Osteopore Ltd. ( ($AU:OSX) ) is now available. Osteopore Limited has announced that the Advance...

1M ago

OSX

Osteopore Secures Clearance for Jawbone Regeneration Study

An announcement from Osteopore Ltd. ( ($AU:OSX) ) is now available. Osteopore Ltd. has received Research Governance Office...

1M ago

OSX

Osteopore Ltd. Sees Shift in Substantial Holder’s Voting Power

Osteopore Ltd. ( ($AU:OSX) ) has issued an update. Osteopore Ltd. has announced a significant change in the...

1M ago

OSX

Osteopore Initiates Groundbreaking Pediatric Study for Temporal Hollowing

Osteopore Ltd. ( ($AU:OSX) ) has shared an announcement. Osteopore Ltd. has announced the recruitment of its first...

1M ago

OSX

OSX FAQ

What was Osteopore Ltd.’s price range in the past 12 months?

Osteopore Ltd. lowest share price was <AU$0.01 and its highest was AU$0.05 in the past 12 months.

What is Osteopore Ltd.’s market cap?

Osteopore Ltd.’s market cap is AU$2.61M.

When is Osteopore Ltd.’s upcoming earnings report date?

Osteopore Ltd.’s upcoming earnings report date is Aug 28, 2025 which is yesterday.

How were Osteopore Ltd.’s earnings last quarter?

Osteopore Ltd. released its earnings results on Feb 28, 2025. The company reported -AU$0.015 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.015.

Is Osteopore Ltd. overvalued?

According to Wall Street analysts Osteopore Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Osteopore Ltd. pay dividends?

Osteopore Ltd. does not currently pay dividends.

What is Osteopore Ltd.’s EPS estimate?

Osteopore Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Osteopore Ltd. have?

Osteopore Ltd. has 237,259,980 shares outstanding.

What happened to Osteopore Ltd.’s price movement after its last earnings report?

Osteopore Ltd. reported an EPS of -AU$0.015 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Osteopore Ltd.?

Currently, no hedge funds are holding shares in AU:OSX

Osteopore Ltd. Stock Smart Score

Underperform

Fundamentals

Return on Equity

-907.51%

Trailing 12-Months

Asset Growth

-6.23%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Osteopore Ltd.

Osteopore Limited designs, develops, and markets bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery applications in Singapore, Australia, and internationally. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company offers Osteoplug, a bioresorbable implant, which is used for covering trephination burr holes in neurosurgery; and Osteomesh, a bioresorbable implant that is used in craniofacial surgery to repair various types of fractures, such as orbital floor fracture, as well as to fill surgical defects. Osteopore Limited has a collaboration agreement with Livingstone Health Holding Limited to jointly develop new applications and products for regenerating bone and tissue. The company was incorporated in 2003 and is headquartered in Singapore.